of versican 1 blocks cigarette-induced loss of insoluble elastin in human lung fibroblasts, Respiratory Physiology and Neurobiology (2015), http://dx.doi.org/10.1016/j.resp.2015. 05.004 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HighlightsWe find extracellular matrix protein versican 1 is in creased by cigarette smoke extract solution in lung fibroblasts.Versican 1 knockdown restore cigarette-related elastin loss through chondroitin sulfate decrease.Exgenous chondroitin sulfate could block the beneficent effect brought by versican 1 knockdown.
Page 2 of 21A c c e p t e d M a n u s c r i p t Abstract COPD lung is characterized by loss of alveolar elastic fibers and an increase in the chondroitin sulfate (CS) matrix proteoglycan versican 1 (V1). V1 is a known inhibitor of elastic fiber deposition and this study investigates the effects of knockdown of V1, and add-back of CS, on CCL-210 lung fibroblasts treated with cigarette smoke extract (CSE) as a model for COPD. CSE inhibited fibroblast proliferation, viability, tropoelastin synthesis, and elastin deposition, and increased V1 synthesis and secretion. V1 siRNA decreased V1 and constituent CS, did not affect tropoelastin production, but blocked the CSE-induced loss in insoluble elastin. Exogenous CS reduced insoluble elastin, even in the presence of V1 siRNA. These findings confirm that V1 and CS impair the assembly of tropoelastin monomers into insoluble fibers, and further demonstrate that specific knockdown of V1 alleviates the impaired assembly of elastin seen in cultures of pulmonary fibroblasts exposed to CSE, indicating a regulatory role for this protein in the pathophysiology of COPD.